Skip to main content
Fig. 3 | Journal of Intensive Care

Fig. 3

From: Efficacy, safety, and pharmacokinetics of MR13A11A, a generic of remifentanil, for pain management of Japanese patients in the intensive care unit: a double-blinded, fentanyl-controlled, randomized, non-inferiority phase 3 study

Fig. 3

Remifentanil concentrations in arterial blood. Remifentanil concentrations in arterial blood were measured 1 h after the start of dosing, immediately before the start of dose reduction leading into weaning from the ventilator, at the end of dosing, and 1, 2, 3, 5, 7, 10, 20 and 60 min after the end of dosing. Concentrations are indicated by mean + standard deviation

Back to article page

Journal of Intensive Care

ISSN: 2052-0492